Abstract
Background: Antiplatelet therapy is a cornerstone in the management of the Acute Coronary syndrome and the prevention of stent thrombosis after PCI. After aspirin clopidogrel is the widely used antiplatelet drug in our country. Many studies showed that clopidogrel resistance is the emerging problem for managing ACS patients and after coronary intervention. But exact data about clopidogrel resistance of Bangladeshi population is still unknown.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
